Additionally, the positive rates of DCP were higher than those of AFP in HCC with different tumor sizes, and in cohort A, the total positive rate of DCP in HCC was 82.6%, which was remarkably higher than that of AFP (67.8%). The gene discussed is ACE; the disease is hepatocellular carcinoma.